SCHEMBL25009162

SCHEMBL25009162

CCSc1oc(-c2ccc(F)cc2)nc1S(=O)(=O)c1ccccc1

nearest known ligand 0.84

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.84
TSHR P16473 5/20 0.84
HSD17B10 Q99714 4/20 0.84
NPSR1 Q6W5P4 3/20 0.84
MAPK1 P28482 1/20 0.84
HPGD P15428 3/20 0.76
HTT P42858 3/20 0.69
LMNA P02545 1/20 0.69
MAPT P10636 10/20 0.67
TP53 P04637 8/20 0.67
SMN1; SMN2 Q16637 3/20 0.67
KDM4E B2RXH2 2/20 0.67
POLB P06746 2/20 0.67
ALOX15 P16050 1/20 0.67
RXFP1 Q9HBX9 1/20 0.65
L3MBTL1 Q9Y468 1/20 0.64
MEN1 O00255 1/20 0.62
KMT2A Q03164 1/20 0.62
THRB P10828 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25009360 0.95 ALDH1A1 (0.84) ALDH1A1TSHRHSD17B10NPSR1MAPK1
SCHEMBL25011047 0.94 KDM4E (0.74) ALDH1A1TSHRHSD17B10NPSR1MAPK1
SCHEMBL25009358 0.91 ALDH1A1 (1.00) ALDH1A1TSHRHSD17B10NPSR1MAPK1
SCHEMBL25009356 0.91 TSHR (0.73) ALDH1A1TSHRHSD17B10NPSR1MAPK1
SCHEMBL25009620 0.89 TSHR (0.75) ALDH1A1TSHRHSD17B10NPSR1MAPK1
SCHEMBL25009333 0.89 TSHR (0.75) ALDH1A1TSHRHSD17B10NPSR1MAPK1
SCHEMBL25009177 0.89 TSHR (0.70) ALDH1A1TSHRHSD17B10NPSR1MAPK1
SCHEMBL25010142 0.88 MAPT (0.77) ALDH1A1TSHRHSD17B10NPSR1MAPK1
SCHEMBL25009354 0.88 MAPT (0.68) ALDH1A1TSHRHSD17B10NPSR1MAPK1
SCHEMBL25011070 0.87 MAPT (0.75) ALDH1A1TSHRHSD17B10NPSR1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230041576-A1 METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230041576-A1 METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY NFKBIA, IKBKB, NFKB2 ALDH1A1 4286/4885TSHR 4634/4885HSD17B10 3884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.